{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:24:00Z","timestamp":1790753040820,"version":"4.1.0"},"reference-count":40,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T00:00:00Z","timestamp":1633996800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPD"],"published-print":{"date-parts":[[2021,10,12]]},"abstract":"<jats:p>Background: \u03b1-synuclein (\u03b1-syn) aggregation contributes to the progression of multiple neurodegenerative diseases. We recently found that the isoform b of the co-chaperone DNAJB6 is a strong suppressor of \u03b1-syn aggregation in vivo and in vitro. However, nothing is known about the role of the endogenous isoform b of DNAJB6 (DNAJB6b) in health and disease, due to lack of specific antibodies. Objective: Here we generated a novel anti-DNAJB6b antibody to analyze the localization and expression of this isoform in cells, in tissue and in clinical material. Methods: To address this we used immunocytochemistry, immunohistochemistry, as well as a novel quantitative DNAJB6 specific ELISA method. Results: The endogenous protein is mainly expressed in the cytoplasm and in neurites in vitro, where it is found more in dendrites than in axons. We further verified in vivo that DNAJB6b is expressed in the dopaminergic neurons of the substantia nigra pars compacta (SNpc), which is a neuronal subpopulation highly sensitive to \u03b1-syn aggregation, that degenerate to a large extend in patients with Parkinson\u2019s disease (PD) and multiple system atrophy (MSA). When we analyzed the expression levels of DNAJB6b in brain material from PD and MSA patients, we found a downregulation of DNAJB6b by use of ELISA based quantification. Interestingly, this was also true when analyzing tissue from patients with progressive supranuclear palsy, a taupathic atypical parkinsonian disorder. However, the total level of DNAJB6 was upregulated in these three diseases, which may indicate an upregulation of the other major isoform of DNAJB6, DNAJB6a. Conclusion: This study shows that DNAJB6b is downregulated in several different neurodegenerative diseases, which makes it an interesting target to further investigate in relation to amyloid protein aggregation and disease progression.<\/jats:p>","DOI":"10.3233\/jpd-202512","type":"journal-article","created":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T13:17:34Z","timestamp":1627391854000},"page":"1791-1803","source":"Crossref","is-referenced-by-count":12,"title":["DNAJB6b is Downregulated in Synucleinopathies"],"prefix":"10.1177","volume":"11","author":[{"given":"Jonas","family":"Folke","sequence":"first","affiliation":[{"name":"Research Laboratory for Stereology and Neuroscience, Bispebjerg-Frederiksberg Hospital, University Hospital of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sertan","family":"Arkan","sequence":"additional","affiliation":[{"name":"Molecular Neurobiology, Department of Experimental Medical Science, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isak","family":"Martinsson","sequence":"additional","affiliation":[{"name":"Experimental Dementia Research Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Aznar","sequence":"additional","affiliation":[{"name":"Research Laboratory for Stereology and Neuroscience, Bispebjerg-Frederiksberg Hospital, University Hospital of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Gouras","sequence":"additional","affiliation":[{"name":"Experimental Dementia Research Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Brudek","sequence":"additional","affiliation":[{"name":"Research Laboratory for Stereology and Neuroscience, Bispebjerg-Frederiksberg Hospital, University Hospital of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hansen","sequence":"additional","affiliation":[{"name":"Molecular Neurobiology, Department of Experimental Medical Science, Lund, Sweden"},{"name":"Department of Technology, University College Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JPD-202512_ref1","first-page":"69","article-title":"The synucleinopathies: twenty years on","volume":"7","author":"Goedert","year":"2017","journal-title":"J Parkinsons Dis"},{"key":"10.3233\/JPD-202512_ref2","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.3233\/JPD-202512_ref3","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S1474-4422(11)70213-7","article-title":"Pathological roles of alpha-synuclein in neurological disorders","volume":"10","author":"Vekrellis","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.3233\/JPD-202512_ref4","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S1474-4422(10)70213-1","article-title":"Are synucleinopathies prion-like disorders?","volume":"9","author":"Angot","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.3233\/JPD-202512_ref5","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.molmed.2012.03.002","article-title":"Beyond alpha-synuclein transfer: pathology propagation in Parkinson\u2019s disease","volume":"18","author":"Hansen","year":"2012","journal-title":"Trends Mol Med"},{"key":"10.3233\/JPD-202512_ref6","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nn.4529","article-title":"alpha-Synuclein promotes dilation of the exocytotic fusion pore","volume":"20","author":"Logan","year":"2017","journal-title":"Nat Neurosci"},{"key":"10.3233\/JPD-202512_ref7","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1126\/science.1195227","article-title":"Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro","volume":"329","author":"Burre","year":"2010","journal-title":"Science"},{"key":"10.3233\/JPD-202512_ref8","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.3233\/JPD-202512_ref9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","article-title":"100 years of Lewy pathology","volume":"9","author":"Goedert","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JPD-202512_ref10","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s12035-012-8325-2","article-title":"Molecular chaperones, alpha-synuclein, and neurodegeneration","volume":"47","author":"Witt","year":"2013","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JPD-202512_ref11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3233\/JPD-191790","article-title":"Protein quality control pathways at the crossroad of synucleinopathies","volume":"10","author":"De Mattos","year":"2020","journal-title":"J Parkinsons Dis"},{"key":"10.3233\/JPD-202512_ref12","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1021\/acs.biochem.5b00459","article-title":"A rational design strategy for the selective activity enhancement of a molecular chaperone toward a target substrate","volume":"54","author":"Aprile","year":"2015","journal-title":"Biochemistry"},{"key":"10.3233\/JPD-202512_ref13","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.molcel.2015.07.012","article-title":"Human Hsp70 disaggregase reverses Parkinson\u2019s-linked alpha-synuclein amyloid fibrils","volume":"59","author":"Gao","year":"2015","journal-title":"Mol Cell"},{"key":"10.3233\/JPD-202512_ref14","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.bbrc.2004.07.021","article-title":"Geldanamycin induces Hsp70 and prevents alpha-synuclein aggregation and toxicity in vitro","volume":"321","author":"McLean","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3233\/JPD-202512_ref15","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1007\/s00018-006-6192-6","article-title":"The diversity of the DnaJ\/Hsp40 family, the crucial partners for Hsp70 chaperones","volume":"63","author":"Qiu","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"10.3233\/JPD-202512_ref16","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2018.01.004","article-title":"Cellular handling of protein aggregates by disaggregation machines","volume":"69","author":"Mogk","year":"2018","journal-title":"Mol Cell"},{"key":"10.3233\/JPD-202512_ref17","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.tibs.2008.12.009","article-title":"Polypeptide transfer from Hsp40 to Hsp70 molecular chaperones","volume":"34","author":"Summers","year":"2009","journal-title":"Trends Biochem Sci"},{"key":"10.3233\/JPD-202512_ref18","doi-asserted-by":"crossref","first-page":"e52099","DOI":"10.1371\/journal.pone.0052099","article-title":"The Type II Hsp40 Sis1 cooperates with Hsp70 and the E3 ligase Ubr1 to promote degradation of terminally misfolded cytosolic protein","volume":"8","author":"Summers","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JPD-202512_ref19","doi-asserted-by":"crossref","first-page":"20160534","DOI":"10.1098\/rstb.2016.0534","article-title":"DNAJ proteins in neurodegeneration: essential and protective factors","volume":"373","author":"Zarouchlioti","year":"2018","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.3233\/JPD-202512_ref20","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/humu.23055","article-title":"Identification of a large DNAJB2 deletion in a family with spinal muscular atrophy and parkinsonism","volume":"37","author":"Sanchez","year":"2016","journal-title":"Hum Mutat"},{"key":"10.3233\/JPD-202512_ref21","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/ana.24553","article-title":"DNAJC6 mutations associated with early-onset Parkinson\u2019s disease","volume":"79","author":"Olgiati","year":"2016","journal-title":"Ann Neurol"},{"key":"10.3233\/JPD-202512_ref22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ana.24591","article-title":"A novel nonsense mutation in DNAJC6 expands the phenotype of autosomal-recessive juvenile-onset Parkinson\u2019s disease","volume":"79","author":"Elsayed","year":"2016","journal-title":"Ann Neurol"},{"key":"10.3233\/JPD-202512_ref23","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/hmg\/ddy003","article-title":"Parkinson\u2019s disease-linked DNAJC13 mutation aggravates alpha-synuclein-induced neurotoxicity through perturbation of endosomal trafficking","volume":"27","author":"Yoshida","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JPD-202512_ref24","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/hmg\/ddt570","article-title":"DNAJC13 mutations in Parkinson disease","volume":"23","author":"Vilarino-Guell","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JPD-202512_ref25","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/s41586-020-2904-6","article-title":"Molecular dissection of amyloid disaggregation by human HSP70","volume":"587","author":"Wentink","year":"2020","journal-title":"Nature"},{"key":"10.3233\/JPD-202512_ref26","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/jnr.21819","article-title":"DnaJB6 is present in the core of Lewy bodies and is highly up-regulated in parkinsonian astrocytes","volume":"87","author":"Durrenberger","year":"2009","journal-title":"J Neurosci Res"},{"key":"10.3233\/JPD-202512_ref27","doi-asserted-by":"crossref","first-page":"9039","DOI":"10.1038\/s41598-017-08324-z","article-title":"The molecular chaperones DNAJB6 and Hsp70 cooperate to suppress alpha-synuclein aggregation","volume":"7","author":"Aprile","year":"2017","journal-title":"Sci Rep"},{"key":"10.3233\/JPD-202512_ref28","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.3390\/ijms20184495","article-title":"The molecular chaperone DNAJB6, but not DNAJB1, suppresses the seeded aggregation of alpha-synuclein in cells","volume":"20","author":"Deshayes","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JPD-202512_ref29","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"10.3233\/JPD-202512_ref30","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1084\/jem.20160368","article-title":"Widespread transneuronal propagation of alpha-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson\u2019s disease","volume":"213","author":"Rey","year":"2016","journal-title":"J Exp Med"},{"key":"10.3233\/JPD-202512_ref31","doi-asserted-by":"crossref","first-page":"8130","DOI":"10.1038\/s41598-020-65046-5","article-title":"Co-chaperones DNAJA1 and DNAJB6 are critical for regulation of polyglutamine aggregation","volume":"10","author":"Rodr\u00edguez-Gonz\u00e1lez","year":"2020","journal-title":"Sci Rep"},{"key":"10.3233\/JPD-202512_ref32","doi-asserted-by":"crossref","first-page":"17225","DOI":"10.1074\/jbc.M112.421685","article-title":"The DNAJB6 and DNAJB8 protein chaperones prevent intracellular aggregation of polyglutamine peptides","volume":"288","author":"Gillis","year":"2013","journal-title":"J Biol Chem"},{"key":"10.3233\/JPD-202512_ref33","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fnmol.2015.00040","article-title":"Evaluation of the amyloid beta-GFP fusion protein as a model of amyloid beta peptides-mediated aggregation: a study of DNAJB6 chaperone","volume":"8","author":"Hussein","year":"2015","journal-title":"Front Mol Neurosci"},{"key":"10.3233\/JPD-202512_ref34","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.molcel.2016.03.017","article-title":"The S\/T-rich motif in the DNAJB6 chaperone delays polyglutamine aggregation and the onset of disease in a mouse model","volume":"62","author":"Kakkar","year":"2016","journal-title":"Mol Cell"},{"key":"10.3233\/JPD-202512_ref35","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3233\/JAD-170262","article-title":"Heterogeneous association of Alzheimer\u2019s disease-linked amyloid-beta and amyloid-beta protein precursor with synapses","volume":"60","author":"Willen","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JPD-202512_ref36","doi-asserted-by":"crossref","first-page":"31066","DOI":"10.1074\/jbc.M114.595124","article-title":"Interaction of the molecular chaperone DNAJB6 with growing amyloid-beta 42 (Abeta42) aggregates leads to sub-stoichiometric inhibition of amyloid formation","volume":"289","author":"Mansson","year":"2014","journal-title":"J Biol Chem"},{"key":"10.3233\/JPD-202512_ref37","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1021\/acs.biochem.8b00353","article-title":"Conserved S\/T residues of the human chaperone DNAJB6 are required for effective inhibition of Abeta42 amyloid fibril formation","volume":"57","author":"Mansson","year":"2018","journal-title":"Biochemistry"},{"key":"10.3233\/JPD-202512_ref38","first-page":"400","article-title":"Neocortical neuronal loss in patients with multiple system atrophy: a stereological study","volume":"27","author":"Salvesen","year":"2017","journal-title":"Cereb Cortex"},{"key":"10.3233\/JPD-202512_ref39","doi-asserted-by":"crossref","first-page":"e1002968","DOI":"10.1371\/journal.ppat.1002968","article-title":"A Hsp40 chaperone protein interacts with and modulates the cellular distribution of the primase protein of human cytomegalovirus","volume":"8","author":"Pei","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.3233\/JPD-202512_ref40","doi-asserted-by":"crossref","first-page":"21529","DOI":"10.1073\/pnas.1914999116","article-title":"Unraveling the structure and dynamics of the human DNAJB6b chaperone by NMR reveals insights into Hsp40-mediated proteostasis","volume":"116","author":"Karamanos","year":"2019","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Parkinson's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JPD-202512","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:49:41Z","timestamp":1777610981000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JPD-202512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,12]]},"references-count":40,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jpd-202512","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,12]]}}}